Prognostic Value of Antithrombin Levels in COVID-19 Patients and Impact of Fresh Frozen Plasma Treatment: A Retrospective Study

İlkay Anaklı Perihan Ergin Özcan Günseli Orhun Gülçin Hilal AlayGülçin Hilal AlayVerda Dinar Tuna Emre ÇeliksoyMehmet KılıçMutlu Mercan Achmet AliSevgi BeşışıkFigen Esen

Published in: Turkish journal of haematology : official journal of Turkish Society of Haematology (2021)

AT activity could be used as a prognostic marker for survival and organ failure in COVID-19-associated ARDS patients. AT supplementation therapy with FFP in patients with COVID-19-induced hypercoagulopathy may improve thrombosis prophylaxis and thus have an impact on survival.

Keyphrases

sars cov
coronavirus disease
free survival
pulmonary embolism
acute respiratory distress syndrome
high glucose
diabetic rats
extracorporeal membrane oxygenation
oxidative stress
intensive care unit
endothelial cells